BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17172070)

  • 1. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature.
    Andiran N; Alikaşifoğlu A; Küpeli S; Yetgin S
    Turk J Pediatr; 2006; 48(3):248-52. PubMed ID: 17172070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
    Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute lymphoblastic leukemia accompanied by severe hypercalcemia; successful treatment with bisphosphonate].
    Ogihara T; Kikuchi Y; Imai Y; Ohsaka A; Isaka M; Oka Y
    Rinsho Ketsueki; 1995 Jan; 36(1):29-34. PubMed ID: 7715075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates for treatment of childhood hypercalcemia.
    Lteif AN; Zimmerman D
    Pediatrics; 1998 Oct; 102(4 Pt 1):990-3. PubMed ID: 9755274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rapid correction of hypercalcemia at presentation of acute lymphoblastic leukemia using high-dose methylprednisolone.
    Unal S; Durmaz E; Erkoçoğlu M; Bayrakçi B; Bircan O; Alikaşifoğlu A; Cetin M
    Turk J Pediatr; 2008; 50(2):171-5. PubMed ID: 18664083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
    Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
    Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature.
    Kolyva S; Efthymiadou A; Gkentzi D; Karana-Ginopoulou A; Varvarigou A
    J Pediatr Endocrinol Metab; 2014 Mar; 27(3-4):349-54. PubMed ID: 23934636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation.
    Attard TM; Dhawan A; Kaufman SS; Collier DS; Langnas AN
    Pediatr Transplant; 1998 May; 2(2):157-9. PubMed ID: 10082449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate.
    Tagiyev A; Demirbilek H; Tavil B; Buyukyilmaz G; Gumruk F; Cetin M
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):232-4. PubMed ID: 26907650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate.
    Cagle AP; Waguespack SG; Buckingham BA; Shankar RR; Dimeglio LA
    Pediatrics; 2004 Oct; 114(4):1091-5. PubMed ID: 15466114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe hypercalcemia complicated in acute lymphoblastic leukemia (ALL) with E2A-HLF fusion gene: report of two cases and literature review].
    Yang J; Zhou X; Wang B; Gao C; Zhang RD; Li B
    Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):615-8. PubMed ID: 19954622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemia in acute lymphoblastic leukemia: an overview.
    Trehan A; Cheetham T; Bailey S
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):424-7. PubMed ID: 19648791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignancy-associated hypercalcemia].
    Oura S
    Nihon Rinsho; 2003 Jun; 61(6):1006-9. PubMed ID: 12806951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD19 negative precursor B acute lymphoblastic leukemia presenting with hypercalcemia.
    Sultan I; Kraveka JM; Lazarchick J
    Pediatr Blood Cancer; 2004 Jul; 43(1):66-9. PubMed ID: 15170892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia.
    Niizuma H; Fujii K; Sato A; Fujiwara I; Takeyama J; Imaizumi M
    Pediatr Blood Cancer; 2007 Dec; 49(7):990-3. PubMed ID: 16496289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairment.
    Yap AS; Hockings GI; Fleming SJ; Khafagi FA
    Clin Nephrol; 1990 Nov; 34(5):225-9. PubMed ID: 2268980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of pamidronate in patients with renal failure and hypercalcemia.
    Machado CE; Flombaum CD
    Clin Nephrol; 1996 Mar; 45(3):175-9. PubMed ID: 8706358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hypercalcemia as a harbinger of acute lymphoblastic leukemia.
    Mittal MK
    Pediatr Emerg Care; 2007 Jun; 23(6):397-400. PubMed ID: 17572525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to treat tumor-induced hypercalcemia].
    Body JJ
    Rev Prat; 2003 Dec; 53(19):2128-35. PubMed ID: 15008469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.